Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2001
03/29/2001WO2001021586A1 Metallo-organo catalyst for polymerizing unsaturated compounds
03/29/2001WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001021169A1 Mch antagonists
03/29/2001WO2001020995A1 Compounds directed against pilus biogenesis and activity in pathogenic bacteria; methods and compositions for synthesis thereof
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001DE10021335A1 New 6-hydroxy-2,3-dihydro-1H-indole derivatives, tricyclic analogs and corresponding glycoside prodrugs, are antitumor agents for use in antibody-directed enzymatic prodrug therapy
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/29/2001CA2385105A1 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
03/29/2001CA2383147A1 Mch antagonists
03/29/2001CA2347837A1 Cycloalkyl bicycloheptene dicarboximides
03/28/2001EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
03/28/2001EP1086179A1 Energy transfer assay method and reagent
03/28/2001EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands
03/28/2001EP1086081A1 Quarternary ammonium compounds as anti-tussive agents
03/28/2001EP1086066A1 Muscarinic receptor antagonists
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP0820446A4 Synthesis of bis-indolylmaleimides
03/28/2001CN1289323A Matrix metalloproteinase inhibitors
03/28/2001CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
03/28/2001CN1063747C Quinotone and naphthyridonecarboxylic acid derivatives
03/27/2001US6208719 Method and apparatus for telecommunications having automatic network adaptations and silent mode operations
03/27/2001US6207860 Fluorinating agents, far less potential of violent decomposition and attendant high gaseous by-product evolvement, useful for deoxofluorination of alcohols and ketones,
03/27/2001US6207836 Indolin-2-one derivatives
03/27/2001US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection
03/27/2001US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors
03/27/2001US6207693 Benzamide derivatives having a vasopressin antagonistic activity
03/27/2001US6207686 Endothelin antagonists
03/27/2001US6207679 Antimicrobial agents uses and compositions related thereto
03/27/2001US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia
03/27/2001US6207672 Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids
03/27/2001US6207421 Nucleotide sequence determination; using deoxyribonucleic acids as templates to synthesize nucleotide sequences, stop synthesis of nucleotide sequences, analyzing the terminated nucleotide sequences
03/27/2001US6207363 Cyan ?nb coupler?
03/27/2001CA2081450C Biologically active peptides containing d-2-alkyltrypthophan
03/22/2001WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors
03/22/2001WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001WO2001019794A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
03/22/2001WO2001019791A2 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/22/2001DE19944993A1 Metallorganische Katalysatoren für die Polymerisation ungesättigter Verbindungen Organometallic catalysts for the polymerization of unsaturated compounds
03/22/2001CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001CA2383988A1 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
03/21/2001EP1085020A1 Synthesis of modified diaminopurines and their incorporation into oligomers
03/21/2001EP1085013A1 Process for the preparation of cyclic N-hydroxy-dicarboximides
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1084114A1 Isothiazole derivatives useful as anticancer agents
03/21/2001EP1084108A1 Spla 2? inhibitor compounds for treatment of disease
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083905A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (dhea) or analogues
03/21/2001EP1083897A1 Hiv integrase inhibitors
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001EP0762877B1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
03/21/2001EP0599886B1 Macromonomers having reactive end groups
03/21/2001CN1288461A Process for preparing sparingly soluble aromatic amines
03/21/2001CN1288460A Process for the prepn. of 3-methyl-2-oxoindoline
03/21/2001CN1063430C Ethanolamine derivatives
03/20/2001US6204389 Cyanine dyes and synthesis methods thereof
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation
03/20/2001US6203580 Oxidative dyeing
03/20/2001US6203579 Use of 1-substituted isatins to dye fibers containing keratin
03/20/2001CA2071529C Diaromatic substituted anti-aids compounds
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase
03/15/2001WO2001017972A2 Novel herbicides
03/15/2001WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
03/15/2001WO2001017962A1 Processes for the preparation of tricyclic amino alcohol derivatives
03/15/2001WO2001017942A1 Amides as inhibitors for pyruvate dehydrogenase
03/15/2001WO2000058286A3 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide
03/15/2001WO2000016810A8 Near infrared fluorescent contrast agent and fluorescence imaging
03/15/2001DE19943508A1 3-Vinylpyrol-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel 3 Vinylpyrol derivatives, processes for their preparation and their use as medicaments
03/15/2001DE19942961A1 Verfahren zur Herstellung von aromatischen Aminen unter Katalyse von Palladaphosphacyclobutanen A process for the preparation of aromatic amines with catalysis by Palladaphosphacyclobutanen
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/15/2001CA2383757A1 Processes for the preparation of tricyclic amino alcohol derivatives
03/15/2001CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1083163A2 Catalytic method for the preparation of aromatic amines using a palladaphosphacyclobutane compound as catalyst
03/14/2001EP1082319A1 Benzocarbazol and indenoinole derived estrogenic agents
03/14/2001EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
03/14/2001EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
03/14/2001EP1082295A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
03/14/2001EP1082121A1 Hiv integrase inhibitors
03/14/2001EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
03/14/2001CN1287117A Cycloene derivate, its producing process and its therapeutical use
03/14/2001CN1063178C Aza-anthracyclinone derivatives
03/13/2001US6201130 N-arylsulfonylamino acid omega-amides
03/13/2001US6201025 For treatment of central nervous system disorders
03/13/2001US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction